274
Views
1
CrossRef citations to date
0
Altmetric
Review

Poppers maculopathy: A quantitative review of previous literature

ORCID Icon, ORCID Icon, ORCID Icon &
Pages 391-398 | Received 29 May 2021, Accepted 16 Sep 2021, Published online: 11 Oct 2021

REFERENCES

  • Asensio-Sanchez VM. “Poppers maculopathy?„ in Spain. A new ophthalmologicaldisease Arch Soc Esp Oftalmol. 2017;92(2):97.
  • Hui M, Galvin J, Chilov M, Gabrielle PH, Fung AT. POPPER MACULOPATHY: LONG-TERM FOLLOW-UP AND CASE SERIES. Retin Cases Brief Rep. 2020;14(2):195–199.
  • Van Bol LB, Kurt RA, Keane PA, Pal B, Sivaprasad S. Clinical phenotypes of poppers maculopathy and their links to visual and anatomic recovery. Ophthalmology. 2017;124(9):1425–1427. doi:10.1016/j.ophtha.2017.05.021.
  • Bral NOG, Marinkovic M, Leroy BP, Hoornaert K, Van Lint M, Ten Tusscher MPM. Do not turn a blind eye to alkyl nitrite (poppers)!. Acta Ophthalmol. 2016;94:e82–e3.
  • Schulze-Dobold C. Retinal toxicity in users of “poppers”. Ann Intern Med. 2012;156(9):670–672. doi:10.7326/0003-4819-156-9-201205010-00021.
  • Davies AJ, Kelly SP, Bhatt PR. ‘Poppers maculopathy’–an emerging ophthalmic reaction to recreational substance abuse. Eye (Lond). 2012;26(6):888. doi:10.1038/eye.2012.37.
  • Davies AJ, Kelly SP, Naylor SG, et al. Adverse ophthalmic reaction in poppers users: case series of ‘poppers maculopathy’. Eye (Lond). 2012;26(11):1479–1486. doi:10.1038/eye.2012.191.
  • Pahlitzsch M, Draghici S, Merinfhar BM. Poppers-Makulopathie. Klinische Monatsblatter fur Augenheilkunde. 2013;230(7):727–732. doi:10.1055/s-0032-1328693.
  • Pahlitzsch M, Mai C, Joussen AM, Bergholz R. Poppers maculopathy: complete restitution of macular changes in OCT after drug abstinence.Semin Ophthalmol.2016;31(5):479–484.
  • Huang J, Huang J, Chen Y, Ying GS. Evaluation of approaches to analyzing continuous correlated eye data when sample size is small. Ophthalmic Epidemiol. 2018;25(1):45–54. doi:10.1080/09286586.2017.1339809.
  • Savary P, Biotti D, Abouaf L, et al. Poppers toxic maculopathy misdiagnosed as atypical optic neuritis. Eur J Neurol. 2013;20(7):e90–e1. doi:10.1111/ene.12148.
  • Caré W, Lepori J-C, Villa A, ed(s). Maculopathie toxique induite par les poppers. 2018;8:241–243.
  • Vignal-Clermont C, Audo I, Sahel J-A PM. Poppers-associated retinal toxicity. N Engl J Med. 2010;363(16):1583–1585. doi:10.1056/NEJMc1005118.
  • Gruener AM, Jeffries MAR, El Housseini Z, Whitefield L. Poppers maculopathy. Lancet. 2014;384(9954):1606. doi:10.1016/S0140-6736(14)60887-4.
  • Law G, Ching G, Docherty G, Navajas E. Acquired bilateral central vision loss in a young adult due to “Poppers Maculopathy”. Jpn J Ophthalmol Res. 2019;1(1):1004. doi:10.31546/JJOAR.1004.
  • Docherty G, Eslami M, O’Donnell H. “Poppers Maculopathy”: a case report and literature review. Can J Ophthalmol J Can D’ophtalmologie. 2018;53(4):e154–e6. doi:10.1016/j.jcjo.2017.10.036.
  • Rojas CN, Fawzi AA, Gill MK. AOSLO imaging in poppers maculopathy shows high resolution loss of central macular cones. Am J Ophthalmol Case Rep. 2021;23:101166. doi:10.1016/j.ajoc.2021.101166.
  • Audo I, El Sanharawi M, Vignal-Clermont C, et al. Foveal damage in habitual poppers users. Arch Ophthalmol. 2011;129(6):703–708.
  • Wunder AF, Oelckers M, Lock G. Partynight outcome. Dtsch Med Wochenschr. 2015;140:1611–1613.
  • Fledelius HC. Irreversible blindness after amyl nitrite inhalation. Acta Ophthalmol Scand. 1999;77(6):719–721. doi:10.1034/j.1600-0420.1999.770625.x.
  • Pece A, Patelli F, Milani P, Pierro L. Transient visual loss after amyl Isobutyl nitrite abuse. Semin Ophthalmol. 2004;19(3–4):105–106. doi:10.1080/08820530490882292.
  • Fujimoto J, The Development SE. Commercialization, and impact of optical coherence tomography. Invest Ophthalmol Vis Sci. 2016;57(9):OCT1–OCT13. doi:10.1167/iovs.16-19963.
  • Davies AJ, Borschmann R, Kelly SP, Ramsey J, Ferris J, Winstock AR. The prevalence of visual symptoms in poppers users: a global survey. BMJ Open Ophthalmol. 2017;1(1):e000015–e. doi:10.1136/bmjophth-2016-000015.
  • Baethge C. The languages of medicine. Dtsch Arztebl Int. 2008;105:37–40.
  • Rabot A, Pinon F, Baillif S. SD-OCT appearance in acute poppers-associated macular toxicity. J francais d’ophtalmologie. 2013;36(4):388–389. doi:10.1016/j.jfo.2012.09.005.
  • Dyrda A, Català-Mora J, Rey A, Díaz-Cascajosa J, Macular Hole V-SM. After poppers (Alkyl Nitrate) Inhalation in a Child. Ophthalmic Surg Lasers Imaging Retina. 2018;49(11):897–900. doi:10.3928/23258160-20181101-12.
  • Raoof N, Bradley P, Theodorou M, Moore AT, Michaelides M. The new pretender: a large UK case series of retinal injuries in children secondary to handheld lasers. Am J Ophthalmol. 2016;171:88–94. doi:10.1016/j.ajo.2016.08.027.
  • Rewbury R, Hughes E, Purbrick R, Prior S, Baron M. Poppers: legal highs with questionable contents? A case series of poppers maculopathy. Br J Ophthalmol. 2017;101(11):1530–1534. doi:10.1136/bjophthalmol-2016-310023.
  • Luis J, Virdi M, Nabili S. Poppers retinopathy. BMJ Case Rep. 2016;2016:bcr2016214442. doi:10.1136/bcr-2016-214442.
  • Fortunati M. Poppers maculopathy: OCT appearance after 10 months of drug abstinence. J francais d’ophtalmologie. 2017;40(2):e49–e50. doi:10.1016/j.jfo.2015.11.020.
  • Sega R, Urbancic M. Waxing and waning poppers maculopathy. Can J Ophthalmol. 2021;56(3):e101–e103. doi:10.1016/j.jcjo.2020.12.006.
  • Ahmadi J, Keane JR, McCormick GS, Fallis RJ, Miller CA. Ischemic chiasmal syndrome and hypopituitarism associated with progressive cerebrovascular occlusive disease. AJNR Am J Neuroradiol. 1984;5:367–372.
  • Romano F, Arrigo A, Sperti A, Bandello F, Battaglia Parodi M. Multimodal imaging of poppers maculopathy. . Eur J Ophthalmol. 2021 Mar;31(2):NP71-NP73. doi:10.1177/1120672119887918.
  • Tomasso L, Benatti L, La Spina C, et al. Optical coherence tomography angiography findings in laser maculopathy. Eur J Ophthalmol. 2017;27(1):e13–e5. doi:10.5301/ejo.5000844.
  • Gonzalez Martin-Moro J, Hernandez Verdejo JL, Zarallo Gallardo J. Photic maculopathy: a review of the literature (ii). Arch Soc Esp Oftalmol. 2018;93(11):542–550. doi:10.1016/j.oftal.2018.06.012.
  • Marneros AG, Fan J, Yokoyama Y, et al. Vascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaris development and visual function. Am J Pathol. 2005;167(5):1451–1459. doi:10.1016/S0002-9440(10)61231-X.
  • Saint-Geniez M, Kurihara T, Sekiyama E, Maldonado AE, D’Amore PA. An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris. Proc Natl Acad Sci U S A. 2009;106(44):18751–18756. doi:10.1073/pnas.0905010106.
  • Fajgenbaum MA. Is the mechanism of ‘poppers maculopathy’ photic injury?. Eye (Lond). 2013;27(12):1420–1421. doi:10.1038/eye.2013.218.
  • Gonzalez Martin-Moro J, Hernandez Verdejo JL, Zarallo Gallardo J. Photic maculopathy: a review of the literature (I). Arch Soc Esp Oftalmol. 2018;93(11):530–541. doi:10.1016/j.oftal.2018.06.010.
  • Fuller DG. Severe solar maculopathy associated with the use of lysergic acid diethylamide (LSD). Am J Ophthalmol. 1976;81(4):413–416. doi:10.1016/0002-9394(76)90295-6.
  • Schatz H, Mendelblatt F. Solar retinopathy from sun-gazing under the influence of LSD. Br J Ophthalmol. 1973;57(4):270–273. doi:10.1136/bjo.57.4.270.
  • Ewald RA. Sun gazing associated with the use of LSD. Ann Ophthalmol. 1971;3:15–17.
  • Masjedi M, Ghanbari A, Bakhodaei HH, Jowkar T, Hosseni V, Rakhshan M. Pupillary response to nitrous oxide administration in cataract surgery under general anesthesia. J Chin Med Assoc. 2017;80(11):733–736. doi:10.1016/j.jcma.2017.07.001.
  • Clemens CR, Alten F, Loos D, Uhlig CE, Heiduschka P, Eter N. Poppers maculopathy or retinopathy?. Eye (Lond). 2015;29(1):148–149. doi:10.1038/eye.2014.252.
  • Bruninx R, Lepiece G. Didactic image poppers maculopathy. Bulletin de la Societe belge d’ophtalmologie2013;(322):133–135.
  • Pahlitzsch M, Salchow D, Rossel M, Bergholz R. Multifokale Elektroretinografie bei Patienten mit Poppers-Makulopathie. Klinische Monatsblatter fur Augenheilkunde. 2019;236(8):1004–1011. doi:10.1055/s-0043-118602.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.